Latest Insights - page 59 | BiopharmaTrend

Halda Therapeutics Secures $126 Million in Series B Extension to Advance RIPTAC Cancer Therapies

Halda Therapeutics, a biotechnology company specializing in cancer treatments, has announced the successful completion of a $126 million Series B extension financing. The funds, which bring the company's total capital …

Continue ›››

Novel AI Framework for Detecting LLM "Hallucinations" in Medical Summaries

Mendel AI, a startup specializing in healthcare artificial intelligence (AI), in collaboration with the University of Massachusetts Amherst (UMass Amherst), has unveiled new research focused on addressing the challenge of …

Continue ›››

Roche Arguably Weighs Sale of Its Health Data Subsidiary Amid Strategic Challenges: A $1.9 Billion Gamble in Question

Roche is reportedly considering the sale of Flatiron Health, a cancer data specialist that it acquired for $1.9 billion in 2018, according to a report by the Financial Times. Flatiron, founded …

Continue ›››

Tampa General Hospital Implements AI-Powered Platform to Improve Operating Room Efficiency

Tampa General Hospital (TGH) has introduced Apella, an artificial intelligence (AI) platform designed to enhance safety and efficiency in its operating rooms. The system provides perioperative teams with real-time data …

Continue ›››

Blood Proteins Provide New Insights into Biological Aging and Disease Risk

A recent study from the University of Oxford reveals that proteins carried in the blood can offer significant insights into biological aging and the risk of age-related diseases. This research, …

Continue ›››

Insilico Medicine's AI-Designed TEAD Inhibitor Receives IND Approval and Orphan Drug Designation from FDA

Insilico Medicine, a clinical-stage biotechnology company specializing in generative AI-driven drug discovery, has announced that its novel compound, ISM6331, has received Investigational New Drug (IND) clearance from the U.S. Food …

Continue ›››

Breaking: In Arguably the Largest AI in Bio Deal, Recursion Acquires UK-based "End-to-End" AI Biotech Exscientia

Recursion Pharmaceuticals, a biotech firm leveraging artificial intelligence (AI) for drug discovery, has announced its acquisition of Exscientia, a smaller rival, for $688 million in an all-stock transaction. The deal, …

Continue ›››

Rollout of the First-Ever Blood Test for Alzheimer's Detection by Unilabs and C2N Diagnostics

Unilabs and C2N Diagnostics have announced a collaboration to launch the first-ever blood test for Alzheimer's disease detection in 75 countries. This partnership aims to enhance diagnostic processes for Alzheimer's …

Continue ›››

Cell Microsystems Introduces Lab Services for Cell Line and Organoid Development

Cell Microsystems has expanded its contract research lab services to include cell line and custom organoid development, utilizing its proprietary CellRaft Technology. This technology facilitates the generation of viable cell …

Continue ›››

3D-Printed Blood Vessels Edge Us Closer to Artificial Organs

Researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and the John A. Paulson School of Engineering and Applied Science (SEAS) have made a leap in the quest to create …

Continue ›››

How to Achieve Successful Digital Transformation in Healthcare

The NHS is under unprecedented strain, with wait and referral times reaching record highs and a £749 million overspend leading to a budget deficit across trusts in the UK. Despite …

Continue ›››

Riverlane Secures $75M for Quantum Error Correction Technology

Riverlane, a company based in Cambridge, UK, has raised $75 million in a Series C funding round to advance its quantum error correction technology. This investment aims to enhance Riverlane's …

Continue ›››